| 发明名称 |
BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS, AND/OR PROGNOSIS FOR RAF INHIBITORS |
| 摘要 |
<p>Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordingly.</p> |
| 申请公布号 |
KR20090071603(A) |
申请公布日期 |
2009.07.01 |
| 申请号 |
KR20097007973 |
申请日期 |
2007.09.19 |
| 申请人 |
NOVARTIS AG |
发明人 |
AZIZ NATASHA;MOLER EDWARD;STUART DARRIN;HEISE CARLA;AARDALEN KIM |
| 分类号 |
C12Q1/68;G01N33/15 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
